191 related articles for article (PubMed ID: 29592883)
1. Gallium Maltolate Disrupts Tumor Iron Metabolism and Retards the Growth of Glioblastoma by Inhibiting Mitochondrial Function and Ribonucleotide Reductase.
Chitambar CR; Al-Gizawiy MM; Alhajala HS; Pechman KR; Wereley JP; Wujek R; Clark PA; Kuo JS; Antholine WE; Schmainda KM
Mol Cancer Ther; 2018 Jun; 17(6):1240-1250. PubMed ID: 29592883
[TBL] [Abstract][Full Text] [Related]
2. The cytotoxicity of gallium maltolate in glioblastoma cells is enhanced by metformin through combined action on mitochondrial complex 1.
Alhajala HS; Markley JL; Kim JH; Al-Gizawiy MM; Schmainda KM; Kuo JS; Chitambar CR
Oncotarget; 2020 Apr; 11(17):1531-1544. PubMed ID: 32391122
[TBL] [Abstract][Full Text] [Related]
3. Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma.
Chua MS; Bernstein LR; Li R; So SK
Anticancer Res; 2006; 26(3A):1739-43. PubMed ID: 16827101
[TBL] [Abstract][Full Text] [Related]
4. Development of gallium compounds for treatment of lymphoma: gallium maltolate, a novel hydroxypyrone gallium compound, induces apoptosis and circumvents lymphoma cell resistance to gallium nitrate.
Chitambar CR; Purpi DP; Woodliff J; Yang M; Wereley JP
J Pharmacol Exp Ther; 2007 Sep; 322(3):1228-36. PubMed ID: 17600139
[TBL] [Abstract][Full Text] [Related]
5. Gallium Complexes as Anticancer Drugs.
Chitambar CR
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394029
[TBL] [Abstract][Full Text] [Related]
6. Development of drug resistance to gallium nitrate through modulation of cellular iron uptake.
Chitambar CR; Zivkovic-Gilgenbach Z; Narasimhan J; Antholine WE
Cancer Res; 1990 Aug; 50(15):4468-72. PubMed ID: 2164439
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of leukemic HL60 cell growth by transferrin-gallium: effects on ribonucleotide reductase and demonstration of drug synergy with hydroxyurea.
Chitambar CR; Matthaeus WG; Antholine WE; Graff K; O'Brien WJ
Blood; 1988 Dec; 72(6):1930-6. PubMed ID: 3058232
[TBL] [Abstract][Full Text] [Related]
8. The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells.
Herbison CE; Thorstensen K; Chua AC; Graham RM; Leedman P; Olynyk JK; Trinder D
Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1567-75. PubMed ID: 19828835
[TBL] [Abstract][Full Text] [Related]
9. Gallium maltolate inhibits human cutaneous T-cell lymphoma tumor development in mice.
Wu X; Wang TW; Lessmann GM; Saleh J; Liu X; Chitambar CR; Hwang ST
J Invest Dermatol; 2015 Mar; 135(3):877-884. PubMed ID: 25371972
[TBL] [Abstract][Full Text] [Related]
10. Potent
Al-Gizawiy MM; Wujek RT; Alhajala HS; Cobb JM; Prah MA; Doan NB; Connelly JM; Chitambar CR; Schmainda KM
Front Oncol; 2023; 13():1278157. PubMed ID: 38288102
[TBL] [Abstract][Full Text] [Related]
11. Quantitative proteomic reveals gallium maltolate induces an iron-limited stress response and reduced quorum-sensing in Pseudomonas aeruginosa.
Piatek M; Griffith DM; Kavanagh K
J Biol Inorg Chem; 2020 Dec; 25(8):1153-1165. PubMed ID: 33125529
[TBL] [Abstract][Full Text] [Related]
12. Targeting iron-dependent DNA synthesis with gallium and transferrin-gallium.
Chitambar CR; Narasimhan J
Pathobiology; 1991; 59(1):3-10. PubMed ID: 1645976
[TBL] [Abstract][Full Text] [Related]
13. Modulation of transferrin receptor mRNA by transferrin-gallium in human myeloid HL60 and lymphoid CCRF-CEM leukaemic cells.
Ul-Haq R; Chitambar CR
Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):873-7. PubMed ID: 8379943
[TBL] [Abstract][Full Text] [Related]
14. Effect of hydroxyurea on cellular iron metabolism in human leukemic CCRF-CEM cells: changes in iron uptake and the regulation of transferrin receptor and ferritin gene expression following inhibition of DNA synthesis.
Chitambar CR; Wereley JP
Cancer Res; 1995 Oct; 55(19):4361-6. PubMed ID: 7671248
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic potential of iron-targeting gallium compounds in human disease: From basic research to clinical application.
Chitambar CR
Pharmacol Res; 2017 Jan; 115():56-64. PubMed ID: 27856328
[TBL] [Abstract][Full Text] [Related]
16. Gallium(III) and iron(III) complexes of alpha-N-heterocyclic thiosemicarbazones: synthesis, characterization, cytotoxicity, and interaction with ribonucleotide reductase.
Kowol CR; Berger R; Eichinger R; Roller A; Jakupec MA; Schmidt PP; Arion VB; Keppler BK
J Med Chem; 2007 Mar; 50(6):1254-65. PubMed ID: 17315858
[TBL] [Abstract][Full Text] [Related]
17. Gallium-induced cell death in lymphoma: role of transferrin receptor cycling, involvement of Bax and the mitochondria, and effects of proteasome inhibition.
Chitambar CR; Wereley JP; Matsuyama S
Mol Cancer Ther; 2006 Nov; 5(11):2834-43. PubMed ID: 17121930
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells.
Chitambar CR; Narasimhan J; Guy J; Sem DS; O'Brien WJ
Cancer Res; 1991 Nov; 51(22):6199-201. PubMed ID: 1933878
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma detection by gallium scan and subsequent treatment by gallium maltolate: rationale and case study.
Bernstein LR; van der Hoeven JJ; Boer RO
Anticancer Agents Med Chem; 2011 Jul; 11(6):585-90. PubMed ID: 21554205
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the antimicrobial activities of gallium nitrate and gallium maltolate against Mycobacterium avium subsp. paratuberculosis in vitro.
Fecteau ME; Aceto HW; Bernstein LR; Sweeney RW
Vet J; 2014 Oct; 202(1):195-7. PubMed ID: 25155307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
